About · Our team

Hannah is a biostatistician with several years of experience working with register-based epidemiological data. She joined Red Door Analytics in 2022, leading the applied team, and became Director of Applied Biostatistics in August 2024.
She maintains an affiliation with the Clinical Epidemiology Division, Department of Medicine Solna at Karolinska Institutet, where she contributes to pharmacoepidemiological projects within the Chronic Inflammatory Disease Epidemiology Research Group.
Publications
38 publications featuring Hannah
Peer-reviewed papers from our full list that Hannah has co-authored. Most recent first.
2026
- Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs—a Swedish nationwide study. Annals of the Rheumatic Diseases 2026. View →
Cite
@article{huss2026, author = {Huss, V. and Bower, H. and Björklund, M. and Hellgren, K. and Frisell, T. and Delcoigne, B. and Di Giuseppe, D. and Askling, J.}, title = {{Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs---a Swedish nationwide study}}, journal = {Annals of the Rheumatic Diseases}, year = {2026}, doi = {10.1016/j.ard.2026.02.015} }TY - JOUR AU - Huss, V. AU - Bower, H. AU - Björklund, M. AU - Hellgren, K. AU - Frisell, T. AU - Delcoigne, B. AU - Di Giuseppe, D. AU - Askling, J. TI - Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs—a Swedish nationwide study JO - Annals of the Rheumatic Diseases PY - 2026 DO - 10.1016/j.ard.2026.02.015 UR - https://doi.org/10.1016/j.ard.2026.02.015 ER -
2025
- Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritis. Annals of the Rheumatic Diseases 2025;84(5):716-725. View →
Cite
@article{molander2025, author = {Molander, V. and Bower, H. and Frisell, T. and Askling, J.}, title = {{Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritis}}, journal = {Annals of the Rheumatic Diseases}, year = {2025}, volume = {84}, number = {5}, pages = {716--725}, doi = {10.1016/j.ard.2025.01.020} }TY - JOUR AU - Molander, V. AU - Bower, H. AU - Frisell, T. AU - Askling, J. TI - Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritis JO - Annals of the Rheumatic Diseases PY - 2025 VL - 84 IS - 5 SP - 716 EP - 725 DO - 10.1016/j.ard.2025.01.020 UR - https://doi.org/10.1016/j.ard.2025.01.020 ER -
- Loss of life expectancy in patients with myeloproliferative neoplasms in Sweden. Haematologica 2025. View →
Cite
@article{leontyeva2025, author = {Leontyeva, Y. and Landtblom, A. R. and Hultcrantz, M. and Lambe, M. and Bower, H. and Lambert, P. C. and Andersson, T. M. L.}, title = {{Loss of life expectancy in patients with myeloproliferative neoplasms in Sweden}}, journal = {Haematologica}, year = {2025}, doi = {10.3324/haematol.2024.286697} }TY - JOUR AU - Leontyeva, Y. AU - Landtblom, A. R. AU - Hultcrantz, M. AU - Lambe, M. AU - Bower, H. AU - Lambert, P. C. AU - Andersson, T. M. L. TI - Loss of life expectancy in patients with myeloproliferative neoplasms in Sweden JO - Haematologica PY - 2025 DO - 10.3324/haematol.2024.286697 UR - https://doi.org/10.3324/haematol.2024.286697 ER -
- Effectiveness of JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study. Arthritis & Rheumatology 2025;77(3):253-262. View →
Cite
@article{eberhard2025, author = {Eberhard, A. and Di Giuseppe, D. and Askling, J. and Bergman, S. and Bower, H. and Chatzidionysiou, K. and Forsblad‐d'Elia, H. and Kastbom, A. and Olofsson, T. and Frisell, T. and Turesson, C.}, title = {{Effectiveness of JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study}}, journal = {Arthritis \& Rheumatology}, year = {2025}, volume = {77}, number = {3}, pages = {253--262}, doi = {10.1002/art.43014} }TY - JOUR AU - Eberhard, A. AU - Di Giuseppe, D. AU - Askling, J. AU - Bergman, S. AU - Bower, H. AU - Chatzidionysiou, K. AU - Forsblad‐d'Elia, H. AU - Kastbom, A. AU - Olofsson, T. AU - Frisell, T. AU - Turesson, C. TI - Effectiveness of JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study JO - Arthritis & Rheumatology PY - 2025 VL - 77 IS - 3 SP - 253 EP - 262 DO - 10.1002/art.43014 UR - https://doi.org/10.1002/art.43014 ER -
2024
- Potential bias introduced by not including multiple time-scales in survival analysis: a simulation study. Communications in Statistics-Simulation and Computation 2024;53(2):993-1006. View →
Cite
@article{batyrbekova2024, author = {Batyrbekova, N. and Bower, H. and Dickman, P. W. and Szulkin, R. and Lambert, P. C. and Andersson, T. M. L.}, title = {{Potential bias introduced by not including multiple time-scales in survival analysis: a simulation study}}, journal = {Communications in Statistics-Simulation and Computation}, year = {2024}, volume = {53}, number = {2}, pages = {993--1006}, doi = {10.1080/03610918.2022.2038626} }TY - JOUR AU - Batyrbekova, N. AU - Bower, H. AU - Dickman, P. W. AU - Szulkin, R. AU - Lambert, P. C. AU - Andersson, T. M. L. TI - Potential bias introduced by not including multiple time-scales in survival analysis: a simulation study JO - Communications in Statistics-Simulation and Computation PY - 2024 VL - 53 IS - 2 SP - 993 EP - 1006 DO - 10.1080/03610918.2022.2038626 UR - https://doi.org/10.1080/03610918.2022.2038626 ER -
2023
- Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 2023;52(2):111-7. View →
Cite
@article{molander2023, author = {Molander, V. and Bower, H. and Askling, J.}, title = {{Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis}}, journal = {Scandinavian Journal of Rheumatology}, year = {2023}, volume = {52}, number = {2}, pages = {111--7}, doi = {10.1080/03009742.2021.2001907} }TY - JOUR AU - Molander, V. AU - Bower, H. AU - Askling, J. TI - Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis JO - Scandinavian Journal of Rheumatology PY - 2023 VL - 52 IS - 2 SP - 111 EP - 7 DO - 10.1080/03009742.2021.2001907 UR - https://doi.org/10.1080/03009742.2021.2001907 ER -
- Evaluation of VTE, MACE,and serious infections among patients with RA treated with baricitinib compared to TNFi: a multi-database study of patients in routine care using disease registries and claims databases. Rheumatology and Therapy 2023;10(1):201-23. View →
Cite
@article{salinas2023, author = {Salinas, C. A. and Louder, A. and Polinski, J. and Zhang, T. C. and Bower, H. and Phillips, S. and others}, title = {{Evaluation of VTE, MACE,and serious infections among patients with RA treated with baricitinib compared to TNFi: a multi-database study of patients in routine care using disease registries and claims databases}}, journal = {Rheumatology and Therapy}, year = {2023}, volume = {10}, number = {1}, pages = {201--23}, doi = {10.1007/s40744-022-00505-1} }TY - JOUR AU - Salinas, C. A. AU - Louder, A. AU - Polinski, J. AU - Zhang, T. C. AU - Bower, H. AU - Phillips, S. TI - Evaluation of VTE, MACE,and serious infections among patients with RA treated with baricitinib compared to TNFi: a multi-database study of patients in routine care using disease registries and claims databases JO - Rheumatology and Therapy PY - 2023 VL - 10 IS - 1 SP - 201 EP - 23 DO - 10.1007/s40744-022-00505-1 UR - https://doi.org/10.1007/s40744-022-00505-1 ER -
- Including uncertainty of the expected mortality rates in the prediction of loss in life expectancy. BMC Medical Research Methodology 2023;23(1):291. View →
Cite
@article{leontyeva2023, author = {Leontyeva, Y. and Lambe, M. and Bower, H. and Lambert, P. C. and Andersson, T. M. L.}, title = {{Including uncertainty of the expected mortality rates in the prediction of loss in life expectancy}}, journal = {BMC Medical Research Methodology}, year = {2023}, volume = {23}, number = {1}, pages = {291}, doi = {10.1186/s12874-023-02118-w} }TY - JOUR AU - Leontyeva, Y. AU - Lambe, M. AU - Bower, H. AU - Lambert, P. C. AU - Andersson, T. M. L. TI - Including uncertainty of the expected mortality rates in the prediction of loss in life expectancy JO - BMC Medical Research Methodology PY - 2023 VL - 23 IS - 1 SP - 291 DO - 10.1186/s12874-023-02118-w UR - https://doi.org/10.1186/s12874-023-02118-w ER -
- Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden. RMD open 2023;9(4):e003648. View →
Cite
@article{bower2023, author = {Bower, H. and Frisell, T. and di Giuseppe, D. and Delcoigne, B. and Lindström, U. and Turesson, C. and others}, title = {{Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden}}, journal = {RMD open}, year = {2023}, volume = {9}, number = {4}, pages = {e003648}, doi = {10.1136/rmdopen-2023-003648} }TY - JOUR AU - Bower, H. AU - Frisell, T. AU - di Giuseppe, D. AU - Delcoigne, B. AU - Lindström, U. AU - Turesson, C. TI - Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden JO - RMD open PY - 2023 VL - 9 IS - 4 SP - e003648 DO - 10.1136/rmdopen-2023-003648 UR - https://doi.org/10.1136/rmdopen-2023-003648 ER -
- Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study. Annals of the Rheumatic Diseases 2023;82(7):911-9. View →
Cite
@article{huss2023, author = {Huss, V. and Bower, H. and Hellgren, K. and Frisell, T. and Askling, J.}, title = {{Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study}}, journal = {Annals of the Rheumatic Diseases}, year = {2023}, volume = {82}, number = {7}, pages = {911--9}, doi = {10.1136/ard-2022-223636} }TY - JOUR AU - Huss, V. AU - Bower, H. AU - Hellgren, K. AU - Frisell, T. AU - Askling, J. TI - Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study JO - Annals of the Rheumatic Diseases PY - 2023 VL - 82 IS - 7 SP - 911 EP - 9 DO - 10.1136/ard-2022-223636 UR - https://doi.org/10.1136/ard-2022-223636 ER -
- Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme. Annals of the Rheumatic Diseases 2023;82(5):601-10. View →
Cite
@article{frisell2023, author = {Frisell, T. and Bower, H. and Morin, M. and Baecklund, E. and Di Giuseppe, D. and Delcoigne, B. and others}, title = {{Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme}}, journal = {Annals of the Rheumatic Diseases}, year = {2023}, volume = {82}, number = {5}, pages = {601--10}, doi = {10.1136/ard-2022-223762} }TY - JOUR AU - Frisell, T. AU - Bower, H. AU - Morin, M. AU - Baecklund, E. AU - Di Giuseppe, D. AU - Delcoigne, B. TI - Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme JO - Annals of the Rheumatic Diseases PY - 2023 VL - 82 IS - 5 SP - 601 EP - 10 DO - 10.1136/ard-2022-223762 UR - https://doi.org/10.1136/ard-2022-223762 ER -
- Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2023;82(2):189-97. View →
Cite
@article{molander2023b, author = {Molander, V. and Bower, H. and Frisell, T. and Delcoigne, B. and Di Giuseppe, D. and Askling, J.}, title = {{Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis}}, journal = {Annals of the Rheumatic Diseases}, year = {2023}, volume = {82}, number = {2}, pages = {189--97}, doi = {10.1136/ard-2022-223050} }TY - JOUR AU - Molander, V. AU - Bower, H. AU - Frisell, T. AU - Delcoigne, B. AU - Di Giuseppe, D. AU - Askling, J. TI - Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis JO - Annals of the Rheumatic Diseases PY - 2023 VL - 82 IS - 2 SP - 189 EP - 97 DO - 10.1136/ard-2022-223050 UR - https://doi.org/10.1136/ard-2022-223050 ER -
- Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis. RMD Open 2023;9(4):e003630. View →
Cite
@article{bower2023b, author = {Bower, H. and Frisell, T. and di Giuseppe, D. and Delcoigne, B. and Askling, J.}, title = {{Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis}}, journal = {RMD Open}, year = {2023}, volume = {9}, number = {4}, pages = {e003630}, doi = {10.1136/rmdopen-2023-003630} }TY - JOUR AU - Bower, H. AU - Frisell, T. AU - di Giuseppe, D. AU - Delcoigne, B. AU - Askling, J. TI - Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis JO - RMD Open PY - 2023 VL - 9 IS - 4 SP - e003630 DO - 10.1136/rmdopen-2023-003630 UR - https://doi.org/10.1136/rmdopen-2023-003630 ER -
2022
- Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision. RMD Open 2022;8(1). View →
Cite
@article{bower2022, author = {Bower, H. and Frisell, T. and di Giuseppe, D. and Delcoigne, B. and Alenius, G. M. and {Baecklund E et al}}, title = {{Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision}}, journal = {RMD Open}, year = {2022}, volume = {8}, number = {1}, doi = {10.1136/rmdopen-2021-001987} }TY - JOUR AU - Bower, H. AU - Frisell, T. AU - di Giuseppe, D. AU - Delcoigne, B. AU - Alenius, G. M. AU - Baecklund E et al TI - Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision JO - RMD Open PY - 2022 VL - 8 IS - 1 DO - 10.1136/rmdopen-2021-001987 UR - https://doi.org/10.1136/rmdopen-2021-001987 ER -
- Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19? Annals of the Rheumatic Diseases 2022;81(3):433-9. View →
Cite
@article{bower2022b, author = {Bower, H. and Frisell, T. and Di Giuseppe, D. and Delcoigne, B. and Askling, J.}, title = {{Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?}}, journal = {Annals of the Rheumatic Diseases}, year = {2022}, volume = {81}, number = {3}, pages = {433--9}, doi = {10.1136/annrheumdis-2021-221461} }TY - JOUR AU - Bower, H. AU - Frisell, T. AU - Di Giuseppe, D. AU - Delcoigne, B. AU - Askling, J. TI - Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19? JO - Annals of the Rheumatic Diseases PY - 2022 VL - 81 IS - 3 SP - 433 EP - 9 DO - 10.1136/annrheumdis-2021-221461 UR - https://doi.org/10.1136/annrheumdis-2021-221461 ER -
- Short-and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice. Rheumatology 2022;61(5):1810-8. View →
Cite
@article{huss2022, author = {Huss, V. and Bower, H. and Wadström, H. and Frisell, T. and Askling, J.}, title = {{Short-and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice}}, journal = {Rheumatology}, year = {2022}, volume = {61}, number = {5}, pages = {1810--8}, doi = {10.1093/rheumatology/keab570} }TY - JOUR AU - Huss, V. AU - Bower, H. AU - Wadström, H. AU - Frisell, T. AU - Askling, J. TI - Short-and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice JO - Rheumatology PY - 2022 VL - 61 IS - 5 SP - 1810 EP - 8 DO - 10.1093/rheumatology/keab570 UR - https://doi.org/10.1093/rheumatology/keab570 ER -
- Assessing the impact of including variation in general population mortality on standard errors of relative survival and loss in life expectancy. BMC Medical Research Methodology 2022;22(1):130. View →
Cite
@article{leontyeva2022, author = {Leontyeva, Y. and Bower, H. and Gauffin, O. and Lambert, P. C. and Andersson, T. M. L.}, title = {{Assessing the impact of including variation in general population mortality on standard errors of relative survival and loss in life expectancy}}, journal = {BMC Medical Research Methodology}, year = {2022}, volume = {22}, number = {1}, pages = {130}, doi = {10.1186/s12874-022-01597-7} }TY - JOUR AU - Leontyeva, Y. AU - Bower, H. AU - Gauffin, O. AU - Lambert, P. C. AU - Andersson, T. M. L. TI - Assessing the impact of including variation in general population mortality on standard errors of relative survival and loss in life expectancy JO - BMC Medical Research Methodology PY - 2022 VL - 22 IS - 1 SP - 130 DO - 10.1186/s12874-022-01597-7 UR - https://doi.org/10.1186/s12874-022-01597-7 ER -
- Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden. Rheumatology 2022;61(9):3596-605. View →
Cite
@article{digiuseppe2022, author = {Di Giuseppe, D. and Lindstrom, U. and Bower, H. and Delcoigne, B. and Frisell, T. and Chatzidionysiou, K. and others}, title = {{Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden}}, journal = {Rheumatology}, year = {2022}, volume = {61}, number = {9}, pages = {3596--605}, doi = {10.1093/rheumatology/keab933} }TY - JOUR AU - Di Giuseppe, D. AU - Lindstrom, U. AU - Bower, H. AU - Delcoigne, B. AU - Frisell, T. AU - Chatzidionysiou, K. TI - Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden JO - Rheumatology PY - 2022 VL - 61 IS - 9 SP - 3596 EP - 605 DO - 10.1093/rheumatology/keab933 UR - https://doi.org/10.1093/rheumatology/keab933 ER -
- Modelling multiple time-scales with flexible parametric survival models. BMC Medical Research Methodology 2022;22(1):290. View →
Cite
@article{batyrbekova2022, author = {Batyrbekova, N. and Bower, H. and Dickman, P. W. and Ravn Landtblom, A. and Hultcrantz, M. and Szulkin, R. and others}, title = {{Modelling multiple time-scales with flexible parametric survival models}}, journal = {BMC Medical Research Methodology}, year = {2022}, volume = {22}, number = {1}, pages = {290}, doi = {10.21203/rs.3.rs-1268869/v1} }TY - JOUR AU - Batyrbekova, N. AU - Bower, H. AU - Dickman, P. W. AU - Ravn Landtblom, A. AU - Hultcrantz, M. AU - Szulkin, R. TI - Modelling multiple time-scales with flexible parametric survival models JO - BMC Medical Research Methodology PY - 2022 VL - 22 IS - 1 SP - 290 DO - 10.21203/rs.3.rs-1268869/v1 UR - https://doi.org/10.21203/rs.3.rs-1268869/v1 ER -
- Flexible parametric survival analysis with multiple timescales: Estimation and implementation using stmt. The Stata Journal 2022;22(3):679-701. View →
Cite
@article{bower2022c, author = {Bower, H. and Andersson, T. M. L. and Crowther, M. J. and Lambert, P. C.}, title = {{Flexible parametric survival analysis with multiple timescales: Estimation and implementation using stmt}}, journal = {The Stata Journal}, year = {2022}, volume = {22}, number = {3}, pages = {679--701}, doi = {10.1177/1536867x221124552} }TY - JOUR AU - Bower, H. AU - Andersson, T. M. L. AU - Crowther, M. J. AU - Lambert, P. C. TI - Flexible parametric survival analysis with multiple timescales: Estimation and implementation using stmt JO - The Stata Journal PY - 2022 VL - 22 IS - 3 SP - 679 EP - 701 DO - 10.1177/1536867x221124552 UR - https://doi.org/10.1177/1536867x221124552 ER -
- COVID-19 clinical outcomes and DMT of MS patients and population-based controls. Annals of Clinical and Translational Neurology 2022;9(9):1449-58. View →
Cite
@article{longinetti2022, author = {Longinetti, E. and Bower, H. and McKay, K. A. and Englund, S. and Burman, J. and Fink, K. and others}, title = {{COVID-19 clinical outcomes and DMT of MS patients and population-based controls}}, journal = {Annals of Clinical and Translational Neurology}, year = {2022}, volume = {9}, number = {9}, pages = {1449--58}, doi = {10.1002/acn3.51646} }TY - JOUR AU - Longinetti, E. AU - Bower, H. AU - McKay, K. A. AU - Englund, S. AU - Burman, J. AU - Fink, K. TI - COVID-19 clinical outcomes and DMT of MS patients and population-based controls JO - Annals of Clinical and Translational Neurology PY - 2022 VL - 9 IS - 9 SP - 1449 EP - 58 DO - 10.1002/acn3.51646 UR - https://doi.org/10.1002/acn3.51646 ER -
2021
- Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study. Annals of the Rheumatic Diseases 2021;80(8):1086-93. View →
Cite
@article{bower2021, author = {Bower, H. and Frisell, T. and Di Giuseppe, D. and Delcoigne, B. and Ahlenius, G. M. and Baecklund, E. and others}, title = {{Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study}}, journal = {Annals of the Rheumatic Diseases}, year = {2021}, volume = {80}, number = {8}, pages = {1086--93}, doi = {10.1136/annrheumdis-2021-219845} }TY - JOUR AU - Bower, H. AU - Frisell, T. AU - Di Giuseppe, D. AU - Delcoigne, B. AU - Ahlenius, G. M. AU - Baecklund, E. TI - Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study JO - Annals of the Rheumatic Diseases PY - 2021 VL - 80 IS - 8 SP - 1086 EP - 93 DO - 10.1136/annrheumdis-2021-219845 UR - https://doi.org/10.1136/annrheumdis-2021-219845 ER -
- Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden. Annals of the Rheumatic Diseases 2021;80(2):169-75. View →
Cite
@article{molander2021, author = {Molander, V. and Bower, H. and Frisell, T. and Askling, J.}, title = {{Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden}}, journal = {Annals of the Rheumatic Diseases}, year = {2021}, volume = {80}, number = {2}, pages = {169--75}, doi = {10.1136/annrheumdis-2020-218419} }TY - JOUR AU - Molander, V. AU - Bower, H. AU - Frisell, T. AU - Askling, J. TI - Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden JO - Annals of the Rheumatic Diseases PY - 2021 VL - 80 IS - 2 SP - 169 EP - 75 DO - 10.1136/annrheumdis-2020-218419 UR - https://doi.org/10.1136/annrheumdis-2020-218419 ER -
- Frailty trajectories in three longitudinal studies of aging: Is the level or the rate of change more predictive of mortality?. Age and Ageing 2021;50(6):2174-2182. View →
Cite
@article{bai2021, author = {Bai, G. and Szwajda, A. and Wang, Y. and Li, X. and Bower, H. and Karlsson, I. K. and Johansson, B. and Dahl Aslan, A. K. and Pedersen, N. L. and Hägg, S. and Jylhävä, J.}, title = {{Frailty trajectories in three longitudinal studies of aging: Is the level or the rate of change more predictive of mortality?}}, journal = {Age and Ageing}, year = {2021}, volume = {50}, number = {6}, pages = {2174--2182}, doi = {10.1093/ageing/afab106} }TY - JOUR AU - Bai, G. AU - Szwajda, A. AU - Wang, Y. AU - Li, X. AU - Bower, H. AU - Karlsson, I. K. AU - Johansson, B. AU - Dahl Aslan, A. K. AU - Pedersen, N. L. AU - Hägg, S. AU - Jylhävä, J. TI - Frailty trajectories in three longitudinal studies of aging: Is the level or the rate of change more predictive of mortality? JO - Age and Ageing PY - 2021 VL - 50 IS - 6 SP - 2174 EP - 2182 DO - 10.1093/ageing/afab106 UR - https://doi.org/10.1093/ageing/afab106 ER -
2020
- Asthma and all-cause mortality in children and young adults: a population-based study. Thorax 2020;75(12):1040-6. View →
Cite
@article{osvald2020, author = {Osvald, E. C. and Bower, H. and Lundholm, C. and Larsson, H. and Brew, B. K. and Almqvist, C.}, title = {{Asthma and all-cause mortality in children and young adults: a population-based study}}, journal = {Thorax}, year = {2020}, volume = {75}, number = {12}, pages = {1040--6}, doi = {10.1136/thoraxjnl-2020-214655} }TY - JOUR AU - Osvald, E. C. AU - Bower, H. AU - Lundholm, C. AU - Larsson, H. AU - Brew, B. K. AU - Almqvist, C. TI - Asthma and all-cause mortality in children and young adults: a population-based study JO - Thorax PY - 2020 VL - 75 IS - 12 SP - 1040 EP - 6 DO - 10.1136/thoraxjnl-2020-214655 UR - https://doi.org/10.1136/thoraxjnl-2020-214655 ER -
- Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis. Clinical Kidney Journal 2020;13(5):821-7. View →
Cite
@article{evans2020, author = {Evans, M. and Bower, H. and Cockburn, E. and Jacobson, S. H. and Barany, P. and Carrero, J. J.}, title = {{Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis}}, journal = {Clinical Kidney Journal}, year = {2020}, volume = {13}, number = {5}, pages = {821--7}, doi = {10.1093/ckj/sfaa054} }TY - JOUR AU - Evans, M. AU - Bower, H. AU - Cockburn, E. AU - Jacobson, S. H. AU - Barany, P. AU - Carrero, J. J. TI - Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis JO - Clinical Kidney Journal PY - 2020 VL - 13 IS - 5 SP - 821 EP - 7 DO - 10.1093/ckj/sfaa054 UR - https://doi.org/10.1093/ckj/sfaa054 ER -
- Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study. Breast Cancer Research and Treatment 2020;182:699-707. View →
Cite
@article{plym2020, author = {Plym, A. and Johansson, A. L. and Bower, H. and Wennstig, A. K. and Fredriksson, I. and Ahlgren, J. and others}, title = {{Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study}}, journal = {Breast Cancer Research and Treatment}, year = {2020}, volume = {182}, pages = {699--707}, doi = {10.1007/s10549-020-05720-4} }TY - JOUR AU - Plym, A. AU - Johansson, A. L. AU - Bower, H. AU - Wennstig, A. K. AU - Fredriksson, I. AU - Ahlgren, J. TI - Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study JO - Breast Cancer Research and Treatment PY - 2020 VL - 182 SP - 699 EP - 707 DO - 10.1007/s10549-020-05720-4 UR - https://doi.org/10.1007/s10549-020-05720-4 ER -
2019
- Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study. Communications in Statistics – Simulation and Computation 2019;50(11):3777-3793. View →
Cite
@article{bower2019, author = {Bower, H. and Crowther, M. J. and Rutherford, M. J. and Andersson, T. M. L. and Clements, M. and Liu, X. and Dickman, P. W. and Lambert, P. C.}, title = {{Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study}}, journal = {Communications in Statistics -- Simulation and Computation}, year = {2019}, volume = {50}, number = {11}, pages = {3777--3793}, doi = {10.1080/03610918.2019.1634201} }TY - JOUR AU - Bower, H. AU - Crowther, M. J. AU - Rutherford, M. J. AU - Andersson, T. M. L. AU - Clements, M. AU - Liu, X. AU - Dickman, P. W. AU - Lambert, P. C. TI - Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study JO - Communications in Statistics – Simulation and Computation PY - 2019 VL - 50 IS - 11 SP - 3777 EP - 3793 DO - 10.1080/03610918.2019.1634201 UR - https://doi.org/10.1080/03610918.2019.1634201 ER -
- Causes of sick leave, disability pension, and death following a breast cancer diagnosis in women of working age. The Breast 2019;45:48-55. View →
Cite
@article{plym2019, author = {Plym, A. and Johansson, A. L. and Bower, H. and Voss, M. and Holmberg, L. and Fredriksson, I. and others}, title = {{Causes of sick leave, disability pension, and death following a breast cancer diagnosis in women of working age}}, journal = {The Breast}, year = {2019}, volume = {45}, pages = {48--55}, doi = {10.1016/j.breast.2019.02.012} }TY - JOUR AU - Plym, A. AU - Johansson, A. L. AU - Bower, H. AU - Voss, M. AU - Holmberg, L. AU - Fredriksson, I. TI - Causes of sick leave, disability pension, and death following a breast cancer diagnosis in women of working age JO - The Breast PY - 2019 VL - 45 SP - 48 EP - 55 DO - 10.1016/j.breast.2019.02.012 UR - https://doi.org/10.1016/j.breast.2019.02.012 ER -
- Potential gain in life years for Swedish women with breast cancer if stage and survival differences between education groups could be eliminated–Three what-if scenarios. The Breast 2019;45:75-81. View →
Cite
@article{bower2019b, author = {Bower, H. and Andersson, T. M. and Syriopoulou, E. and Rutherford, M. J. and Lambe, M. and Ahlgren, J. and others}, title = {{Potential gain in life years for Swedish women with breast cancer if stage and survival differences between education groups could be eliminated--Three what-if scenarios}}, journal = {The Breast}, year = {2019}, volume = {45}, pages = {75--81}, doi = {10.1016/j.breast.2019.03.005} }TY - JOUR AU - Bower, H. AU - Andersson, T. M. AU - Syriopoulou, E. AU - Rutherford, M. J. AU - Lambe, M. AU - Ahlgren, J. TI - Potential gain in life years for Swedish women with breast cancer if stage and survival differences between education groups could be eliminated–Three what-if scenarios JO - The Breast PY - 2019 VL - 45 SP - 75 EP - 81 DO - 10.1016/j.breast.2019.03.005 UR - https://doi.org/10.1016/j.breast.2019.03.005 ER -
2018
- Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients. Leukemia 2018;32(10):2203-10. View →
Cite
@article{landtblom2018, author = {Landtblom, A. R. and Bower, H. and Andersson, T. M. L. and Dickman, P. W. and Samuelsson, J. and Björkholm, M. and others}, title = {{Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients}}, journal = {Leukemia}, year = {2018}, volume = {32}, number = {10}, pages = {2203--10}, doi = {10.1038/s41375-018-0027-y} }TY - JOUR AU - Landtblom, A. R. AU - Bower, H. AU - Andersson, T. M. L. AU - Dickman, P. W. AU - Samuelsson, J. AU - Björkholm, M. TI - Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients JO - Leukemia PY - 2018 VL - 32 IS - 10 SP - 2203 EP - 10 DO - 10.1038/s41375-018-0027-y UR - https://doi.org/10.1038/s41375-018-0027-y ER -
- Adjusting expected mortality rates using information from a control population: an example using socioeconomic status. American Journal of Epidemiology 2018;187(4):828-36. View →
Cite
@article{bower2018, author = {Bower, H. and Andersson, T. M. L. and Crowther, M. J. and Dickman, P. W. and Lambe, M. and Lambert, P. C.}, title = {{Adjusting expected mortality rates using information from a control population: an example using socioeconomic status}}, journal = {American Journal of Epidemiology}, year = {2018}, volume = {187}, number = {4}, pages = {828--36}, doi = {10.1093/aje/kwx303} }TY - JOUR AU - Bower, H. AU - Andersson, T. M. L. AU - Crowther, M. J. AU - Dickman, P. W. AU - Lambe, M. AU - Lambert, P. C. TI - Adjusting expected mortality rates using information from a control population: an example using socioeconomic status JO - American Journal of Epidemiology PY - 2018 VL - 187 IS - 4 SP - 828 EP - 36 DO - 10.1093/aje/kwx303 UR - https://doi.org/10.1093/aje/kwx303 ER -
- Loss in working years after a breast cancer diagnosis. British Journal of Cancer 2018;118(5):738-43. View →
Cite
@article{plym2018, author = {Plym, A. and Bower, H. and Fredriksson, I. and Holmberg, L. and Lambert, P. C. and Lambe, M.}, title = {{Loss in working years after a breast cancer diagnosis}}, journal = {British Journal of Cancer}, year = {2018}, volume = {118}, number = {5}, pages = {738--43}, doi = {10.1038/bjc.2017.456} }TY - JOUR AU - Plym, A. AU - Bower, H. AU - Fredriksson, I. AU - Holmberg, L. AU - Lambert, P. C. AU - Lambe, M. TI - Loss in working years after a breast cancer diagnosis JO - British Journal of Cancer PY - 2018 VL - 118 IS - 5 SP - 738 EP - 43 DO - 10.1038/bjc.2017.456 UR - https://doi.org/10.1038/bjc.2017.456 ER -
2017
- Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England. British Journal of Cancer 2017;117(9):1419-26. View →
Cite
@article{syriopoulou2017, author = {Syriopoulou, E. and Bower, H. and Andersson, T. M. and Lambert, P. C. and Rutherford, M. J.}, title = {{Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England}}, journal = {British Journal of Cancer}, year = {2017}, volume = {117}, number = {9}, pages = {1419--26}, doi = {10.1038/bjc.2017.300} }TY - JOUR AU - Syriopoulou, E. AU - Bower, H. AU - Andersson, T. M. AU - Lambert, P. C. AU - Rutherford, M. J. TI - Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England JO - British Journal of Cancer PY - 2017 VL - 117 IS - 9 SP - 1419 EP - 26 DO - 10.1038/bjc.2017.300 UR - https://doi.org/10.1038/bjc.2017.300 ER -
- The ORACLE Children Study: educational outcomes at 11 years of age following antenatal prescription of erythromycin or co-amoxiclav. Archives of Disease in Childhood - Fetal and Neonatal Edition 2017;102(2):F131-F135. View →
Cite
@article{marlow2017, author = {Marlow, N. and Bower, H. and Jones, D. and Brocklehurst, P. and Kenyon, S. and Pike, K. and Taylor, D. and Salt, A.}, title = {{The ORACLE Children Study: educational outcomes at 11 years of age following antenatal prescription of erythromycin or co-amoxiclav}}, journal = {Archives of Disease in Childhood - Fetal and Neonatal Edition}, year = {2017}, volume = {102}, number = {2}, pages = {F131--F135}, doi = {10.1136/archdischild-2015-310144} }TY - JOUR AU - Marlow, N. AU - Bower, H. AU - Jones, D. AU - Brocklehurst, P. AU - Kenyon, S. AU - Pike, K. AU - Taylor, D. AU - Salt, A. TI - The ORACLE Children Study: educational outcomes at 11 years of age following antenatal prescription of erythromycin or co-amoxiclav JO - Archives of Disease in Childhood - Fetal and Neonatal Edition PY - 2017 VL - 102 IS - 2 SP - F131-F135 DO - 10.1136/archdischild-2015-310144 UR - https://doi.org/10.1136/archdischild-2015-310144 ER -
2016
- strcs: A command for fitting flexible parametric survival models on the log-hazard scale. The Stata Journal 2016;16(4):989-1012. View →
Cite
@article{bower2016, author = {Bower, H. and Crowther, M. J. and Lambert, P. C.}, title = {{strcs: A command for fitting flexible parametric survival models on the log-hazard scale}}, journal = {The Stata Journal}, year = {2016}, volume = {16}, number = {4}, pages = {989--1012}, doi = {10.1177/1536867x1601600410} }TY - JOUR AU - Bower, H. AU - Crowther, M. J. AU - Lambert, P. C. TI - strcs: A command for fitting flexible parametric survival models on the log-hazard scale JO - The Stata Journal PY - 2016 VL - 16 IS - 4 SP - 989 EP - 1012 DO - 10.1177/1536867x1601600410 UR - https://doi.org/10.1177/1536867x1601600410 ER -
- Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population. Journal of Clinical Oncology 2016;34(24):2851-7. View →
Cite
@article{bower2016b, author = {Bower, H. and Björkholm, M. and Dickman, P. W. and Höglund, M. and Lambert, P. C. and Andersson, T. M. L.}, title = {{Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population}}, journal = {Journal of Clinical Oncology}, year = {2016}, volume = {34}, number = {24}, pages = {2851--7}, doi = {10.1200/jco.2015.66.2866} }TY - JOUR AU - Bower, H. AU - Björkholm, M. AU - Dickman, P. W. AU - Höglund, M. AU - Lambert, P. C. AU - Andersson, T. M. L. TI - Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population JO - Journal of Clinical Oncology PY - 2016 VL - 34 IS - 24 SP - 2851 EP - 7 DO - 10.1200/jco.2015.66.2866 UR - https://doi.org/10.1200/jco.2015.66.2866 ER -
- Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life. Blood cancer journal 2016;6(2):e390-0. View →
Cite
@article{bower2016c, author = {Bower, H. and Andersson, T. M. and Björkholm, M. and Dickman, P. and Lambert, P. C. and {Derolf ÅR}}, title = {{Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life}}, journal = {Blood cancer journal}, year = {2016}, volume = {6}, number = {2}, pages = {e390--0}, doi = {10.1038/bcj.2016.3} }TY - JOUR AU - Bower, H. AU - Andersson, T. M. AU - Björkholm, M. AU - Dickman, P. AU - Lambert, P. C. AU - Derolf ÅR TI - Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life JO - Blood cancer journal PY - 2016 VL - 6 IS - 2 SP - e390-0 DO - 10.1038/bcj.2016.3 UR - https://doi.org/10.1038/bcj.2016.3 ER -